Silencing of tissue factor by antisense deoxyoligonucleotide mitigates thioacetamide-induced liver injury

M S Abdel-Bakky1,2, G K Helal3,4, E M El-Sayed3

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, 11751, Egypt. M.AbdelBakky@qu.edu.sa.

Abstract

Insights

Loss of retinoid receptors (RAR-α and RXR-α) in hepatic stellate cells contributes to liver injury during thioacetamide-induced toxicity. Tissue factor antisense therapy restored receptor levels and reduced liver damage.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cellular Biology

Background:

  • Retinoid receptors (RAR-α, RXR-α) are transcription factors regulating cell functions.
  • Hepatic stellate cells (HSCs) store retinoids and release RRs upon activation.

Purpose of the Study:

  • To investigate if the loss of RAR-α and RXR-α from HSCs during thioacetamide (TAA)-induced liver injury is dependent on tissue factor (TF).

Main Methods:

  • Assessed liver toxicity markers, TF, fibrin, cleaved caspase-3, and cyclin D1.
  • Examined histopathology in TAA-treated mice with and without TF-antisense (AS) treatment.
  • Compared results with vehicle-treated and control mice.

Main Results:

  • TAA injection increased TF, fibrin, cleaved caspase-3, and cyclin D1, with a strong downregulation of RAR-α and RXR-α.
  • TF-AS treatment normalized all investigated parameters and histopathology.
  • TF-AS treatment alleviated RAR-α/RXR-α loss and suppressed apoptosis in TAA-induced liver toxicity.

Conclusions:

  • Downregulation of RAR-α and RXR-α may cause liver injury and HSC activation in TAA-induced toxicity.
  • TF-AS treatment downregulates TF, restores RAR-α/RXR-α, and reduces apoptosis.
  • TF and RAR-α/RXR-α are key regulators in TAA-induced acute liver injury.